Unlock instant, AI-driven research and patent intelligence for your innovation.

Crystalline forms of dmxaa sodium salt

A technology of sodium salt and crystal form, applied in organic chemistry, antineoplastic drugs, drug combination, etc., can solve problems such as difficult to obtain uniformity and change

Inactive Publication Date: 2010-11-03
ANTISOMA RES LTD
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, the amount of water present in a single sample can vary significantly over time due to the environmental conditions to which it is exposed
Because the content of water in the amorphous form is difficult to control, it is difficult to obtain the required uniformity during the preparation of fixed dose DMXAA sodium salt

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystalline forms of dmxaa sodium salt
  • Crystalline forms of dmxaa sodium salt
  • Crystalline forms of dmxaa sodium salt

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0257] Abbreviations appearing in the examples and other parts have the following meanings:

[0258]

[0259]

[0260] experiment:

[0261] X-ray Powder Diffraction (PXRD): PXRD uses CuK α Ray (K α1 with K α2 The ratio is 2:1) on a Philips 1710 X-ray powder diffractometer. X-ray powder diffraction measurements are done in reflectance mode. Interplanar spacing d at wavelength Calculated from the 2θ values ​​below. Usually the error of the 2θ value is ±0.1 to ±0.2°. Therefore, the experimental error of the interplanar spacing depends on the peak position.

[0262] Raman spectrum: The Fourier transform Raman spectrum generated when the sample was irradiated by a near-infrared Nd:YAG laser at 1064 nm was recorded in a Bruker RFS 100 Fourier transform Raman system, and detected with a germanium detector cooled by liquid nitrogen. Each sample with a resolution of 2cm -1 64 scans were accumulated and a laser power of 100 mW was typically applied.

[0263] DSC: Differ...

Embodiment A1

[0280] 897 mg of the DMXAA sodium salt methanolate form M of Reference Example was dissolved in 4.0 mL of water at room temperature. The solution was filtered through a 0.2 μm Millipore filter device into a 250 mL round bottom flask where the solution was frozen at -78°C with solid carbon dioxide (dry ice). Thereafter, it was freeze-dried using a Christ Beta 2-8, L9-2 type freeze dryer under the conditions of a pressure of 0.090 mbar and a freezing temperature of -89°C. After freeze-drying for 18 hours, the resulting dry powder was subjected to X-ray powder diffraction and Raman spectroscopy. The X-ray powder diffraction pattern has a single characteristic peak at 2θ=25.7°, which is a typical mesomorph or amorphous, and is called crystal form A (or mesomorph A). The X-ray powder diffraction pattern of crystal form A is as follows figure 2 shown.

[0281] Stability: Mesogen Form A is ambient stable for at least 2 months when stored in a sealed container under nitrogen.

[...

Embodiment B1

[0284] Example B 1: Preparation of Form B from Mesomorph Form A

[0285] About 50 mg of DMXAA sodium salt mesomorph form A in Example A1 was stored at 40° C. in a humidity chamber at a relative humidity of 75% (corresponding to a water activity of 0.75) for about 5 days. Unexpectedly, the X-ray powder diffraction pattern of this sample shows that what is obtained is a new crystal form, and its X-ray powder diffraction pattern is as follows image 3 As shown, its peak position is shown in Table 2 below. The Raman spectrum of crystal form B is as Figure 14 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
solubility (mass)aaaaaaaaaa
solubility (mass)aaaaaaaaaa
Login to View More

Abstract

The present invention relates to pharmaceutically stable crystalline forms of (5, 6-Dimethyl-9- oxo-9H-xanthene-4-yl) acetic acid (DMXAA) sodium salt,- processes for preparing those stable crystalline forms; pharmaceutical compositions comprising at least one of those crystalline forms in solid form or in dissolved form and a pharmaceutically acceptable carrier. Disclosed are methods of using those pharmaceutical compositions to treat tumours, optionally in combination with other active pharmaceutical agents.

Description

[0001] Cross References to Related Applications [0002] This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 60 / 981,929, filed October 23, 2007, which is hereby incorporated by reference in its entirety. technical field [0003] The present invention relates to a pharmaceutically stable crystal form of 5,6-dimethyl-oxo-xanthene-4-acetic acid (DMXAA) sodium salt, a method for preparing the stable crystal form, comprising at least A pharmaceutical composition of the crystal form and a pharmaceutically acceptable carrier is used in a method of treating tumors using these pharmaceutical compositions optionally in combination with other active drugs. Background technique [0004] (5,6-Dimethyl-9-oxo-9H-xanthene-4-yl)acetic acid (DMXAA) having the following formula was first disclosed as compound 34 in European patent EP 0278176. [0005] [0006] This compound is an antineoplastic agent with multiple activities, including the ability t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D311/86
CPCC07D311/86A61P11/00A61P13/08A61P15/00A61P35/00A61P43/00
Inventor 弗里茨·布拉特罗尔夫·希尔菲克
Owner ANTISOMA RES LTD